| Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical … T Caballero, ML Baeza, R Cabañas, A Campos, S Cimbollek, ... Journal of investigational allergology & clinical immunology 21 (5), 333-47 …, 2011 | 181 | 2011 |
| Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situations T Caballero, ML Baeza, R Cabañas, A Campos, S Cimbollek, ... J Investig Allergol Clin Immunol 21 (6), 422-441, 2011 | 146 | 2011 |
| Oral plasma kallikrein inhibitor for prophylaxis in hereditary angioedema E Aygören-Pürsün, A Bygum, V Grivcheva-Panovska, M Magerl, J Graff, ... New England Journal of Medicine 379 (4), 352-362, 2018 | 116 | 2018 |
| Development of a disease-specific quality of life questionnaire for adult patients with hereditary angioedema due to C1 inhibitor deficiency (HAE-QoL): Spanish multi-centre … N Prior, E Remor, C Gómez-Traseira, C López-Serrano, R Cabañas, ... Health and Quality of Life Outcomes 10, 1-9, 2012 | 68 | 2012 |
| Management of Pregnancy and Delivery in Patients With Hereditary Angioedema Due to C1 Inhibitor Deficiency. T González-Quevedo, JI Larco, C Marcos, M Guilarte, ML Baeza, ... Journal of investigational allergology & clinical immunology 26 (3), 161-167, 2016 | 61 | 2016 |
| Efficacy and Safety of Hizentra®, a New 20% Immunoglobulin Preparation for Subcutaneous Administration, in Pediatric Patients with Primary Immunodeficiency M Borte, M Pac, M Serban, T Gonzalez-Quevedo, B Grimbacher, S Jolles, ... Journal of clinical immunology 31, 752-761, 2011 | 54 | 2011 |
| Hereditary angioedema with F12 mutation: Clinical features and enzyme polymorphisms in 9 Southwestern Spanish families M Piñero-Saavedra, T González-Quevedo, BS de San Pedro, C Alcaraz, ... Annals of Allergy, Asthma & Immunology 117 (5), 520-526, 2016 | 32 | 2016 |
| On the pathogenicity of the plasminogen K330E mutation for hereditary angioedema AE Germenis, G Loules, M Zamanakou, F Psarros, T González-Quevedo, ... Allergy 73 (8), 1751-1753, 2018 | 30 | 2018 |
| Tolerance of a cluster schedule on the treatment of seasonal allergic respiratory disease with pollen extracts quantified in mass units. C Moreno, L Fernandez-Tavora, S Acero, MD Alonso, MJ Barasona, ... Journal of Investigational Allergology & Clinical Immunology 13 (4), 221-227, 2003 | 27 | 2003 |
| The synthetic Kunitz domain protein DX-88 to treat angioedema in patients with hereditary angioedema T Gonzalez-Quevedo, M Cicardi, K Bork, A Williams Int Immunopharmacol 2, 1318, 2002 | 24 | 2002 |
| Tolerance and short-term effect of a cluster schedule with pollen-extracts quantified in mass-units P Guardia, C Moreno, JL Justicia, J Conde, M Cimarra, M Díaz, F Guerra, ... Allergologia et immunopathologia 32 (5), 271-277, 2004 | 22 | 2004 |
| Deciphering the genetics of primary angioedema with normal levels of C1 inhibitor G Loules, F Parsopoulou, M Zamanakou, D Csuka, M Bova, ... Journal of Clinical Medicine 9 (11), 3402, 2020 | 20 | 2020 |
| Management of angioedema without urticaria in the emergency department M Pedrosa, A Prieto-García, A Sala-Cunill, ... Annals of Medicine 46 (8), 607-618, 2014 | 20 | 2014 |
| Prospective safety study of immunotherapy administered in a cluster schedule P Serrano, J Algorta, A Martinez, T Gonzalez-Quevedo, E Velazquez, ... J Investig Allergol Clin Immunol 14 (4), 312-9, 2004 | 18 | 2004 |
| DX-88 a recombinant inhibitor of human plasma kallikrein. Efficacy and safety in hereditary and acquired angioedema M Cicardi, T González-Quevedo, T Caballero, K Bork, A Williams MOLECULAR IMMUNOLOGY 40 (2-4), 197-198, 2003 | 13 | 2003 |
| Angioedema due to acquired deficiency of C1-inhibitor: a cohort study in Spain and a comparison with other series ML Baeza, T González-Quevedo, T Caballero, M Guilarte, R Lleonart, ... The Journal of Allergy and Clinical Immunology: In Practice 10 (4), 1020-1028, 2022 | 10 | 2022 |
| The genetics of hereditary angioedema: A review M Piñero-Saavedra, T González-Quevedo Journal of Rare Diseases Research & Treatment 2 (4), 2017 | 10 | 2017 |
| Spanish Consensus on the Diagnosis, Management And Treatment of Angio-Oedema Mediated by Bradykinin. Part I. Classification, Epidemiology, Pathophysiology, Genetics, Clinical … T Caballero, ML Baeza, R Cabañas, A Campos, S Cimbollek, ... J Investig Allergol Clin Immunol 21 (5), 333-347, 2011 | 8 | 2011 |
| Plasminogen glycoforms alteration and activation susceptibility associated with the missense variant p. Lys330Glu in HAE-PLG patients F Parsopoulou, D Charignon, M Tengo, F Psarros, C Maas, ... Allergy 75 (8), 2099-2102, 2020 | 7 | 2020 |
| DX-88 a recombinant inhibitor of human plasma kallikrein. Evalation of efficacy and safety in patients with hereditary angioedema T Williams, M Cicardi, K Bork, T Gonzalez-Quevedo, T Caballero JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY 111 (4), 908-908, 2003 | 6 | 2003 |
Teresa CaballeroAllergy Department, Hospital Universitario La Paz, IdiPaz, Madrid, SpainVerified email at idipaz.es
